Convert FDA data into investable signals.
Monitor adverse events, manufacturing inspections, compliance observations and emerging drug-safety trends through automated regulatory intelligence feeds built for healthcare investment research.
Discuss your data requirementsFDA Adverse Event Monitoring
Form 483 Inspection Alerts
Drug Safety Change Detection
Custom Healthcare Data Feeds
Detect regulatory risk before it gets priced in.
FDA databases contain valuable signals on drug safety, manufacturing quality, regulatory scrutiny and competitive positioning. Liberty Metrics transforms fragmented public sources into structured, continuously monitored datasets designed for investment research workflows.
FDA Adverse Event Intelligence
Identify emerging drug risks earlier
Track changes in reported adverse events and safety patterns across products and companies, without manually reviewing thousands of individual records.
- Serious adverse event and mortality reports
- Unexpected side-effect clusters
- Drug-specific safety trends
- Competitive and peer comparisons
- New or changing safety signals
FDA Form 483 Inspection Tracker
Monitor manufacturing and compliance risk
Follow newly published inspection observations and compliance findings to gain visibility into manufacturing and quality-related developments.
- Manufacturing and quality-system observations
- Company-specific inspection activity
- Regulatory scrutiny and compliance concerns
- Newly released inspection documents
- Custom company and facility monitoring
Drug Safety Change Detection
Surface meaningful changes across large datasets
Investment teams need more than another data dump. Our monitoring workflows identify changes against defined products, companies, time periods and research priorities.
- Newly reported safety events
- Significant trend shifts
- Product- and company-level rollups
- Historical trend analysis
- Configurable alert thresholds and rules
Regulatory Alternative Data
Build proprietary signals from public sources
We collect, normalize and monitor complex regulatory sources, then shape the output around your team’s investment research process.
- FDA adverse event datasets
- Inspection and compliance records
- Drug safety filings and regulatory updates
- Changes to selected FDA publications
- Custom healthcare monitoring workflows
From fragmented records to actionable workflows
Configure monitoring around the companies, products, therapeutic areas and regulatory events that matter to your coverage universe.
Commercial risk assessment: Monitor developments that may influence a product’s commercial outlook or competitive position.
Launch and post-approval monitoring: Follow selected products as new safety and regulatory information becomes available.
Competitive intelligence: Compare activity across companies, products and relevant peer groups.
Healthcare long/short research: Incorporate structured regulatory observations into broader fundamental research workflows.
Company and portfolio monitoring: Prioritize alerts for a defined list of issuers, assets, facilities or therapeutic areas.
Historical analysis: Access normalized records and time-series views to support longitudinal analysis.
Built around your research process
Our team works with you to define the sources, entities, update cadence and delivery format required by your analysts.
- Define coverage: Select companies, drugs, facilities, event types and relevant FDA sources.
- Collect and normalize: Automate source monitoring and organize records into consistent, usable data.
- Detect changes: Apply configurable rules to identify new records and material changes.
- Deliver intelligence: Send structured feeds and alerts into your existing research workflow.
Data delivered the way your team works.
Whether you need a recurring dataset, targeted alerts or a custom monitoring workflow, we can tailor collection and delivery to your requirements.
- Email alerts
- Cloud delivery
- API integration
- Custom research feeds
FDA records are public regulatory information and may be incomplete, delayed or subject to reporting limitations. Adverse event reports do not establish causation. Liberty Metrics provides data collection, structuring and monitoring services; outputs are not investment advice and should be assessed alongside other research.
Related Solutions
Related Case Studies
SEC.gov Scraping and Monitoring
A financial consultancy firm based in New York City asked Liberty Metrics to build a solution to monitor filing updates from SEC.gov website. ...
Legal - SEC Data Extraction, Investment Research – Web Data
Find regulatory signals relevant to your coverage.
Tell us which companies, products or FDA datasets your team follows. We’ll work with you to scope a monitoring solution aligned with your research requirements.
Contact Liberty Metrics
At Liberty Metrics we don't just have clients. We have partnerships. We view your business as an extension of ours.
We tailor our technology to your business needs. We do it while maintaining a high level of respect and confidentiality for your business.
We value responsiveness, contact us now and we will reply within an hour.
Don't like forms? Give us a call.